<?xml version="1.0" encoding="UTF-8"?>
<p>Moving forward there are treatment options available that could be utilized clinically during the ongoing SARS-CoV-2 epidemic. Some of the broad-spectrum antiviral drugs may be effective for SARS-CoV-2, and there is opportunity to test them in the current scenario of pneumonia in Wuhan, China. Broad-range combinational therapies, including lopinavir and interferon antiviral peptides, can also be evaluated and examined, as these agents have shown significant effects against MERS in nonhuman primates (
 <xref rid="B1" ref-type="bibr">1</xref>). The design and development of novel broad-spectrum antiviral drugs that can potentially target all coronaviruses may prove to be the best treatment option against reemerging and circulating coronaviruses.
</p>
